Careers Contact Us Adverse Event Reporting Media All the latest news and events Newsletter signup Keep up to date with news about Consilient Health and the healthcare sector. Signup Upcoming Events Having enjoyed previous online events, Consilient Health will participate in the following events, whether they are in the form of traditional congresses or if they are online: IPLS 15-17 September 2021 Brighton, UK BIO-Europe 25-27 October 2021 Online event CPhI 9-11 November 2021 Milan, Italy Jefferies London Healthcare Conference November 16-18 2021 London, UK / Online event J.P. Morgan Annual Healthcare Conference 10-13 January 2022 San Francisco, USA Please contact us if you are interested in meeting. Code No: CORP-CH-470(3) Date of Preparation: August 2021 News 2021 Survey from the Royal Osteoporosis Society 26 October 2021 At Consilient Health, our vision has patients at its centre. With this in mind we want to share the important […] Read more > Agreement signed with Diurnal Group plc is extended to the Nordic region 23 February 2021 Having signed a marketing and distribution agreement with Diurnal Group plc in September 2020 for Alkindi® and pipeline products in […] Read more > Agreement signed with Aeterna Zentaris GmbH for European Rights to Macimorelin 7 December 2020 Consilient Health are pleased to announce an exclusive agreement to licence macimorelin acetate 60mg for Europe, from Aeterna Zentaris GmbH, […] Read more > Changes to Consilient Health’s Board 16 November 2020 Consilient Health is pleased to announce the appointment of John Fagan as Finance Director and member of the board. Prior […] Read more > Distribution agreement signed for Theramex Portfolio in Republic of Ireland and the Nordics 17 September 2020 Consilient Health are pleased to announce an agreement with Theramex to market, sell and distribute a range of Theramex’s women’s […] Read more > Agreement signed for Alkindi® and future pipeline products with Diurnal Group plc 8 September 2020 Consilient Health are pleased to announce the signing of a marketing and distribution agreement with Diurnal Group plc for Alkindi®, […] Read more > Agreement signed for Mictonorm® and Mictonet® with APOGEPHA Arzneimittel GmbH 18 June 2020 Consilient Health are pleased to announce the signing of an exclusive licence, distribution and sales promotion agreement with APOGEPHA Arzneimittel […] Read more > Sustainability Champion appointed 16 June 2020 Consilient Health are pleased to announce the appointment of Karen Pulley as Sustainability Champion. CEO, Ahmed Al-Derzi, commented on the […] Read more > COVID19 Pandemic – Consilient Health Statement 27 March 2020 In response to the COVID19 pandemic, Consilient Health has put in place several measures to safeguard the health of our […] Read more > Dr Roger Wu appointed as Chief Operating Officer 14 February 2020 The management team at Consilient Health has been further strengthened by the appointment of Dr Roger Wu into the newly […] Read more > 1 2 Next page In this section Media Newsletter Signup Share this page Code No: CORP-CH-642 Date of Preparation: October 2021 © Consilient Health Ltd. All rights reserved. For Pharmacovigilance or Medical enquiries please: E: drugsafety@consilienthealth.com T: +44 (0)203 751 1888 Privacy Policy Legal Notice Modern Slavery Statement Cookies Sitemap Website by ab... About Cookies We use cookies to improve your browsing experience. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation and analyse site usage. You can modify your cookie preferences by clicking on cookie settings within our Cookie Policy Accept All Cookies Reject All Cookies Settings